ROBERT OLSON: Open Payments
NPI 1356320279 · MANKATO, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 12 payments from 9 companies in 2025. Trend: 2023 $111 · 2024 $310 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| HARMONY BIOSCIENCES LLC | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| Neuronetics, Inc. | 1 | $30 |
| Indivior Inc. | 1 | $18 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
| Soleno Therapeutics, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: Qelbree, WAKIX, FANAPT, NEUROSTAR TMS THERAPY SYSTEM, SUBLOCADE, NUPLAZID, VYKAT XR, VRAYLAR.
Industry payments across MN — which companies pay providers there.
